Journal of Functional Foods-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2024-02-18 ms8000000941838223 来自北京

请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？

83 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2024-05-23 壁虎来自四川省

投稿命中率:50.0
偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群
经验分享：经验分享：
2024-2-25 submission
2024-03-25 major revision
2024-04-21 重新提交修改稿，with edtior
2024-05-11 minor revision
2024-05-21 重新提交修改稿, with edtior
2024-05-23 Accept

78 0

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2023-06-27 178Ob6 来自北京

为什么PubMed和WOS搜不到呀

99 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2024-01-12 ms3000000331499189 来自北京

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：中药;肠道菌群
经验分享：正在投稿中，期待好消息

98 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2023-01-30 Sweet123 来自山东省

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2022-11-07 submission
2022-12-21 Under Review
2023-01-05 Required Reviews Completed, major revision
2023-01-28 重新提交修改稿, with edtior
2023-01-29 Accept

209 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2024-02-07 ms6000002095545543 来自河南省

审稿速度:2.0
偏重的研究方向：食品功能
经验分享：返修中，期待有好消息

169 0

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2023-08-01 ms8000001972745472 来自河南省

想问一下这个杂志可选非OA吗？版面费太贵了

89 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2019-07-22 120fb885m31(暂无昵称)

请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表:
四个月了还在under review

Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review

201 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2019-12-06 Todbio

这个杂志的文章为什么在pubmed搜不到？

199 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2187884, encodeId=fc93218e884ce, content=请问大家，第一次投稿JFF，with editor后直接decision in process是拒稿吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=83, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=452a8502928, createdName=ms8000000941838223, createdTime=Sun Feb 18 08:03:27 CST 2024, time=2024-02-18, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2206250, encodeId=3d97220625054, content=投稿命中率:50.0 偏重的研究方向：营养与疾病模型;营养与健康;肠道菌群 经验分享：经验分享： 2024-2-25 submission 2024-03-25 major revision 2024-04-21 重新提交修改稿，with edtior 2024-05-11 minor revision 2024-05-21 重新提交修改稿, with edtior 2024-05-23 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cf531961440, createdName=壁虎, createdTime=Thu May 23 16:37:27 CST 2024, time=2024-05-23, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2145064, encodeId=c0e72145064ca, content=为什么PubMed和WOS搜不到呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=44b15326055, createdName=178Ob6, createdTime=Tue Jun 27 18:35:51 CST 2023, time=2023-06-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2181071, encodeId=a29021810e106, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：中药;肠道菌群 经验分享：正在投稿中，期待好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13435547176, createdName=ms3000000331499189, createdTime=Fri Jan 12 22:29:17 CST 2024, time=2024-01-12, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2112105, encodeId=1b9121121052b, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2022-11-07 submission 2022-12-21 Under Review 2023-01-05 Required Reviews Completed, major revision 2023-01-28 重新提交修改稿, with edtior 2023-01-29 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=209, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=21d92362370, createdName=Sweet123, createdTime=Mon Jan 30 12:06:58 CST 2023, time=2023-01-30, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2186348, encodeId=dbc72186348eb, content=审稿速度:2.0 偏重的研究方向：食品功能 经验分享：返修中，期待有好消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d538538122, createdName=ms6000002095545543, createdTime=Wed Feb 07 13:19:12 CST 2024, time=2024-02-07, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2150747, encodeId=3c822150e474b, content=想问一下这个杂志可选非OA吗？版面费太贵了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=89, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad808404158, createdName=ms8000001972745472, createdTime=Tue Aug 01 10:32:16 CST 2023, time=2023-08-01, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=573893, encodeId=f4455e3893bf, content=请问后面接受了吗？Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, beContent=Cminor的忧郁 2019-04-29 00:00:00 发表: 四个月了还在under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=201, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f5042220513, createdName=120fb885m31(暂无昵称), createdTime=Mon Jul 22 00:00:00 CST 2019, time=2019-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581042, encodeId=f3ba58104245, content=这个杂志的文章为什么在pubmed搜不到？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=199, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d2f1675433, createdName=Todbio, createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056315, encodeId=1c49105631504, content=这个杂志的文章，为什么知网和pub med都搜不到呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/e31c71b7378048e29cf3e99f8858c0da/f8a0c38f56ec4460ac9c91ae10e0571a.jpg, createdBy=c39f5362798, createdName=ms7866968361536942, createdTime=Wed Sep 29 23:31:20 CST 2021, time=2021-09-29, status=1, ipAttribution=)]

2021-09-29 ms7866968361536942

这个杂志的文章，为什么知网和pub med都搜不到呢？

149 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务